Japan, March 27 -- MITSUBISHI TANABE PHARMA CORP has got intellectual property rights for 'HUMAN ANTI-IL-33 NEUTRALIZING MONOCLONAL ANTIBODY.' Other related details are as follows:

Application Number: JP,2024-134557

Category (FI): A61K39/395@D,A61K39/395@N,A61P1/04,A61P1/16,A61P11/00,A61P11/02,A61P11/06,A61P13/12,A61P17/00,A61P19/02,A61P25/00,A61P35/00,A61P37/08,A61P43/00,A61P9/00,C07K16/00,C07K16/18,C07K16/24,C07K16/46,C12N15/13,C12N15/62@Z,C12P21/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Aug. 9, 2024

Publication Date: Nov. 6, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....